You are here: Industry Insights > Dynavax

News List

COVID-19 S-Trimer vaccine candidates show promise in early trials europeanpharmaceuticalreview
December 08, 2020
When adjuvanted with GSK’s pandemic adjuvant system, the S-Trimer vaccine candidates induced the production of neutralising antibodies in all trial participants.
Medigen, Dynavax COVID-19 Vaccine Receives Taiwan, China Government Subsidy americanpharmaceuticalreview
October 19, 2020
Medigen Vaccine Biologics and Dynavax Technologies announced that MVC has obtained a China's Taiwan, China government subsidy for successfully initiating a Phase 1 clinical trial in Taiwan, China.
Valneva inks €1.37bn Covid-19 vaccine supply deal with UK pharmaceutical-technology
September 16, 2020
Speciality vaccines developer Valneva has announced a partnership worth €1.37bn with the UK Government to supply its inactivated Covid-19 vaccine candidate, VLA2001.
Valneva, Dynavax Enter COVID-19 Vax Supply Pact contractpharma
September 16, 2020
Dynavax will supply CpG 1018 to produce up to 100 million doses of VLA2001 vaccine in 2021.
Dynavax and Medigen partner to develop adjuvanted Covid-19 vaccine pharmaceutical-technology
July 27, 2020
US-based Dynavax Technologies has partnered with Taiwan, China-based Medigen Vaccine Biologics to develop an adjuvanted Covid-19 vaccine candidate.
Dynavax, Queensland University and CEPI work on Covid-19 vaccine pharmaceutical-technology
March 04, 2020
Biopharmaceutical firm Dynavax Technologies has partnered with the University of Queensland (UQ) and Coalition for Epidemic Preparedness (CEPI) for the development of a Covid-19 vaccine.
Vectura allows Dynavax access to smart inhalers pharmatimes
August 17, 2017
Vectura has signed an exclusive global agreement with Dynavax Technologies allowing use of its proprietary smart nebuliser technology to deliver an investigational immunotherapeutic to lung cancer patients.

Previous page 1 2 Next page